PANXEON reads three signals to catch pancreatic cancer sooner
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Editor's Top Picks
One AI watchdog now covers every ward in Abu Dhabi
A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…
Your one-stop resource for medical news and education.
Ultrahuman banks $70M from Qualcomm and Labcorp for health AI
Qualcomm Ventures and Labcorp back Ultrahuman's $70M round as the ring maker expands its health AI platform.
FDA pilot lets generative AI health apps launch without premarket review
Cadence and Limbic are among four products accepted into the FDA's TEMPO pilot for release before authorization.
Oura carries 42 billion hours of health data into its IPO
Oura's IPO paperwork reveals $1.21B in nine-month revenue and a 42 billion hour biometric trove.
Insilico’s compact MMAI models outdo dedicated drug discovery tools
Insilico's MMAI Gym specialist models post winning scores across drug discovery benchmarks.
One voice foundation model could unite ALS and Parkinson’s tracking
A new npj Digital Medicine perspective urges one shared voice model for ALS and Parkinson's disease.
Altman-backed Merge Labs licenses Butterfly chips to link brains
Merge Labs licenses Butterfly Network's ultrasound chips to build brain-computer interfaces.
California sends Newsom a bill to ban AI chatbot therapy
California's legislature passes SB 903, banning AI bots from offering therapy.
China clears Mprosevir, its first AI-assisted Class 1 drug
NMPA clears Westlake's Mprosevir, China's first AI-assisted Class 1 drug.